IP Verse

Elpen Pharmaceutical Co. Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Elpen Pharmaceutical Co. Inc.

Patent Number:
EP3626270
Title:
New Use
Applicant:
NOVARTIS AG
Opposition Date:
Jul 11, 2024
Patent Number:
EP2959894
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
NOVARTIS AG
Opposition Date:
Oct 20, 2022

Competitors of Elpen Pharmaceutical Co. Inc.

NOVARTIS AG

Want to track Elpen Pharmaceutical Co. Inc.?

Feel free to send us a message here and we will get back to you